Published in BMC Infect Dis on October 16, 2004
Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis. Rheumatology (Oxford) (2012) 1.21
Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review. Clin Rheumatol (2006) 1.06
Value of anti-infective chemoprophylaxis in primary systemic vasculitis: what is the evidence? Arthritis Res Ther (2009) 0.99
Current understanding of Pneumocystis immunology. Future Microbiol (2010) 0.94
Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii on the fully automated BD MAX platform. J Clin Microbiol (2013) 0.91
Complications of long-term therapy for ANCA-associated systemic vasculitis. Nat Rev Nephrol (2012) 0.86
Conditions in subjects with rheumatic diseases: pulmonary manifestations of vasculitides. Arthritis Res Ther (2011) 0.83
Early warning scores generated in developed healthcare settings are not sufficient at predicting early mortality in Blantyre, Malawi: a prospective cohort study. PLoS One (2013) 0.83
The CD4 Lymphocyte Count is a Better Predictor of Overall Infection Than the Total Lymphocyte Count in ANCA-Associated Vasculitis Under a Corticosteroid and Cyclophosphamide Regimen: A Retrospective Cohort. Medicine (Baltimore) (2015) 0.80
B cells modulate systemic responses to Pneumocystis murina lung infection and protect on-demand hematopoiesis via T cell-independent innate mechanisms when type I interferon signaling is absent. Infect Immun (2014) 0.78
[Medicinal prophylaxis during intensified immunosuppression in children and adolescents : part 2]. Z Rheumatol (2013) 0.75
Pneumocystis pneumonia (PCP) and Pneumocystis jirovecii carriage in renal transplantation patients: a single-centre experience. Wien Klin Wochenschr (2014) 0.75
Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med (1992) 13.29
Detection of Pneumocystis carinii with DNA amplification. Lancet (1990) 5.50
Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis). Br Med J (1958) 5.38
The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. N Engl J Med (1990) 4.25
Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med (1977) 3.97
Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc (1996) 2.65
A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis (2002) 2.57
Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. Am J Respir Crit Care Med (1995) 2.31
Pneumocystis carinii pneumonia in patients receiving immunosuppressive drugs for dermatological diseases. Br J Dermatol (1999) 2.12
Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis (2000) 2.08
DNA sequences identical to Pneumocystis carinii f. sp. carinii and Pneumocystis carinii f. sp. hominis in samples of air spora. J Clin Microbiol (1996) 1.98
Identification of antigens and antibodies specific for Pneumocystis carinii. J Immunol (1988) 1.81
Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. Medicine (Baltimore) (1987) 1.67
Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. Ann Intern Med (2002) 1.57
Clusters of Pneumocystis carinii pneumonia: analysis of person-to-person transmission by genotyping. QJM (1998) 1.54
Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med (1987) 1.52
Transmission of Pneumocystis carinii DNA from a patient with P. carinii pneumonia to immunocompetent contact health care workers. J Clin Microbiol (2000) 1.50
Pneumocystis carinii, an opportunist in immunocompromised patients. Clin Microbiol Rev (1991) 1.47
[Pneumocystis carnii pneumonia]. Med Klin (1974) 1.42
Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumatol (1994) 1.37
Wide variation in lymphocyte steroid sensitivity among healthy human volunteers. J Clin Endocrinol Metab (1999) 1.36
Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. An analysis of 78 cases. Arch Intern Med (1996) 1.33
Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis (2002) 1.32
Emerging trends in the epidemiology of invasive mycoses in England and Wales (1990-9). Epidemiol Infect (2001) 1.31
An outbreak of Pneumocystis carinii pneumonia in homosexual men. Ann Intern Med (1982) 1.27
Recent advances in the diagnosis, treatment, and prevention of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother (1990) 1.23
Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality. Arthritis Rheum (1999) 1.19
Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection. Chest (2000) 1.19
Pneumocystis carinii pneumonia in human immunodeficiency virus (HIV)-positive and HIV-negative immunocompromised patients. Clin Infect Dis (1999) 1.19
Comparison of four methods for rapid detection of Pneumocystis carinii in respiratory specimens. J Clin Microbiol (1990) 1.16
Pulmonary colonization with Pneumocystis carinii in human immunodeficiency virus-negative patients: assessing risk with blood CD4+ T cell counts. Clin Infect Dis (1999) 1.06
Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis/dermatomyositis or systemic lupus erythematosus. J Rheumatol (1996) 0.96
Risk for Pneumocystis carinii transmission among patients with pneumonia: a molecular epidemiology study. Emerg Infect Dis (2003) 0.96
Use of low-dose trimethoprim-sulfamethoxazole thrice weekly for primary and secondary prophylaxis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (1991) 0.95
Factors associated with Pneumocystis carinii pneumonia in Wegener's granulomatosis. Ann Rheum Dis (1995) 0.94
Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia. J Rheumatol (1992) 0.93
Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults. Med J Aust (1995) 0.89
Improved detection of Pneumocystis carinii by an immunofluorescence technique using monoclonal antibodies. Eur J Clin Microbiol Infect Dis (1990) 0.86
Fulminant Pneumocystis carinii pneumonia in 4 patients with dermatomyositis. Arch Intern Med (1997) 0.85
Presence of Pneumocystis carinii DNA in pond water. J Eukaryot Microbiol (1998) 0.83
Wegener's granulomatosis: long-term follow-up of patients treated with pulse cyclophosphamide. Br J Rheumatol (1998) 0.82
Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Semin Respir Infect (1993) 0.80
STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med (2011) 3.11
Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis. N Engl J Med (2013) 2.63
Identification of naive or antigen-experienced human CD8(+) T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8(+) T cell response. J Immunol (2002) 1.73
Rapid CD8+ T cell repertoire focusing and selection of high-affinity clones into memory following primary infection with a persistent human virus: human cytomegalovirus. J Immunol (2007) 1.56
Schistosomal colonic polyposis in an HIV-positive man. AIDS (2007) 1.42
Differential costimulation through CD137 (4-1BB) restores proliferation of human virus-specific "effector memory" (CD28(-) CD45RA(HI)) CD8(+) T cells. Blood (2007) 1.18
Impaired T(H)17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Allergy Clin Immunol (2010) 1.01
Long-term stable expanded human CD4+ T cell clones specific for human cytomegalovirus are distributed in both CD45RAhigh and CD45ROhigh populations. J Immunol (2004) 0.96
European guideline on chronic pruritus. Acta Derm Venereol (2012) 0.92
Late diversification in the clonal composition of human cytomegalovirus-specific CD8+ T cells following allogeneic hemopoietic stem cell transplantation. Blood (2003) 0.89
The genome of the sparganosis tapeworm Spirometra erinaceieuropaei isolated from the biopsy of a migrating brain lesion. Genome Biol (2014) 0.86
Human cytomegalovirus-specific immunity following haemopoietic stem cell transplantation. Blood Rev (2003) 0.85
Large HIV-specific CD8 cytotoxic T-lymphocyte (CTL) clones reduce their overall size but maintain high frequencies of memory CTL following highly active antiretroviral therapy. Immunology (2006) 0.83
A multinational outbreak of histoplasmosis following a biology field trip in the Ugandan rainforest. J Travel Med (2013) 0.83
Mortality in Clostridium difficile infection: a prospective analysis of risk predictors. Eur J Gastroenterol Hepatol (2013) 0.81
Clinical and pharmacogenetic influences on response to hydroxychloroquine in discoid lupus erythematosus: a retrospective cohort study. J Invest Dermatol (2011) 0.81
Treatment of pruritus associated with systemic disorders in the elderly: a review of the role of new therapies. Drugs Aging (2003) 0.78
Opioid antagonist for pruritus of cholestasis unmasking bony metastases. Acta Derm Venereol (2009) 0.75